Topics

endocrine disruptor

March 22, 2013

EFSA publishes EDC report

EFSA suggests risk assessment for endocrine disrupting chemicals (EDCs) and raises criticisms from NGOs and industry

Reading time: 2 minutes

March 14, 2013

European Parliament adopts report on endocrine disruptors

Report sends clear message to the European Commission to act on endocrine disrupting chemicals

Reading time: 1 minute

February 25, 2013

American Chemistry Council criticizes data evaluation method of UN EDC report

American Chemistry Council agrees with need of further EDC research, but criticizes the data evaluation method of the report on EDCs by the UNEP and WHO

Reading time: 1 minute

February 19, 2013

Breaking News: WHO and UNEP publish EDC report

WHO and UNEP State of the Science report calls uncertainties and knowledge gaps on EDCs too important to ignore, better testing methods and more comprehensive research required

Reading time: 2 minutes

February 11, 2013

What are the reasons for declining fertility in men?

French study finds declining fertility amongst French men since the 1990s, researchers speculate about the reasons

Reading time: 1 minute

February 11, 2013

Safety concerns regarding triclosan persist

Regulatory safety evaluation of triclosan comes under critique as FDA review is delayed

Reading time: 1 minute

February 5, 2013

EFSA: Scientific Committee meets to discuss endocrine disruption

EFSA’s Scientific Committee will discuss endocrine disruption and chemical mixtures during its plenary session

Reading time: 0 minutes

January 24, 2013

European Parliament sends clear message to European Commission to act on EDCs

ENVI Committee of the European Parliament adopts DRAFT report on endocrine disruptors

Reading time: 1 minute

January 22, 2013

New York Times: Endocrine Disruptors, the culprits of increasing obesity rates

The New York Times publishes an article discussing the role of endocrine disruptors in increasing obesity rates around the world

Reading time: 1 minute

January 18, 2013

BPA replacement also interferes with the endocrine system at low doses

New study shows that BPS, a BPA replacement, leads to cell proliferation at low doses and interferes with normal estradiol induced signaling pathways

Reading time: 1 minute
Scroll to Top